HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allele-specific down-regulation of MHC class I antigens in Burkitt lymphoma lines.

Abstract
We have reported that Burkitt lymphomas (BL) that arise in HLA-A11 positive individuals are resistant to lysis by HLA-A11-specific and HLA-A11-restricted CTLs(10,11). Here we show that this phenomenon can be explained by a selective loss of the HLA-A11 polypeptide. The HLA-A11 negative phenotype is due to a regulatory phenomenon, rather than a structural defect, as proven by the ability to rescue expression of HLA-A11 in in vitro Epstein-Barr virus (EBV)-converted sublines of EBV negative BLs.
AuthorsM G Masucci, N J Stam, S Torsteinsdottir, J J Neefjes, G Klein, H L Ploegh
JournalCellular immunology (Cell Immunol) Vol. 120 Issue 2 Pg. 396-400 (May 1989) ISSN: 0008-8749 [Print] Netherlands
PMID2541930 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Histocompatibility Antigens Class I
Topics
  • Alleles
  • Burkitt Lymphoma (immunology)
  • Genes, MHC Class I
  • Herpesvirus 4, Human
  • Histocompatibility Antigens Class I (analysis)
  • Humans
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: